Live Breaking News & Updates on Pharma stock down

Stay informed with the latest breaking news from Pharma stock down on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pharma stock down and stay connected to the pulse of your community

Valeo Pharma (TSE:VPH) Stock Price Down 14.3%

Valeo Pharma (TSE:VPH) Stock Price Down 14.3%
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada , Valeo-pharma , Enerzair-breezhaler , Atectura-breezhaler , Valeo-pharma-company-profile , Valeo-pharma-inc , Get-free-report , Pharma-stock-down , Pharma-inc , Idiopathic-parkinson , Valeo-pharma-daily ,

Lisa Anson Acquires 115,000 Shares of Redx Pharma Plc (LON:REDX) Stock

Redx Pharma Plc (LON:REDX – Get Free Report) insider Lisa Anson purchased 115,000 shares of the firm’s stock in a transaction on Tuesday, April 16th. The shares were acquired at an average cost of GBX 9 ($0.11) per share, with a total value of £10,350 ($12,884.35). Lisa Anson also recently made the following trade(s): On […]

United-kingdom , Redx-pharma , Lisa-anson , Redx-pharma-plc , Get-free-report , Pharma-stock-down , Pharma-plc , Redx-pharma-daily , Lon-redx , Redx , Medical , Insider-trading

Valeo Pharma (TSE:VPH) Hits New 1-Year Low at $0.13

Valeo Pharma Inc. (TSE:VPH – Get Free Report) reached a new 52-week low on Friday . The stock traded as low as C$0.13 and last traded at C$0.13, with a volume of 88571 shares trading hands. The stock had previously closed at C$0.16. Valeo Pharma Stock Down 16.1 % The firm has a market cap […]

Canada , Enerzair-breezhaler , Atectura-breezhaler , Valeo-pharma , Valeo-pharma-company-profile , Valeo-pharma-inc , Get-free-report , Pharma-stock-down , Pharma-inc , Idiopathic-parkinson , Valeo-pharma-daily , Tse-vph

Evoke Pharma (NASDAQ:EVOK) Research Coverage Started at StockNews.com

Investment analysts at StockNews.com began coverage on shares of Evoke Pharma (NASDAQ:EVOK – Get Free Report) in a research report issued on Wednesday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. Evoke Pharma Stock Down 6.5 % Evoke Pharma stock opened at $0.54 on Wednesday. The firm’s 50-day simple moving average […]

Pharma-inc , Pharma-company-profile , Evoke-pharma , Get-free-report , Pharma-stock-down , Evoke-pharma-daily , Nasdaq-evok , Evok , Medical , Initiated-coverage , Stocknews-com

Royalty Pharma (NASDAQ:RPRX) Price Target Cut to $38.00

Royalty Pharma (NASDAQ:RPRX) Price Target Cut to $38.00
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United-states , South-korea , America , Korea , Korea-investment , Jpmorgan-chase-co , Synovus-financial-corp , Goldman-sachs-group , Victory-capital-management-inc , Northern-trust-corp , Barclays-plc

Royalty Pharma (NASDAQ:RPRX) Lifted to "Buy" at StockNews.com

Royalty Pharma (NASDAQ:RPRX) Lifted to "Buy" at StockNews.com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United-states , Ohio , Roryb-riggs , Financial-services-group-inc , Goldman-sachs-group , Virtu-financial , Jpmorgan-chase-co , Royalty-pharma , Free-report , Pharma-stock-down , Get-free-report

Ocuphire Pharma, Inc. (NASDAQ:OCUP) CFO Acquires $21,000.00 in Stock

Ocuphire Pharma, Inc. (NASDAQ:OCUP – Get Free Report) CFO Nirav S. Jhaveri purchased 10,000 shares of the company’s stock in a transaction on Thursday, March 21st. The shares were purchased at an average price of $2.10 per share, with a total value of $21,000.00. Following the completion of the purchase, the chief financial officer now […]

Niravs-jhaveri , Ocuphire-pharma , Geode-capital-management , Nasdaq , Renaissance-technologies , Blackrock-inc , Prelude-capital-management , Ocuphire-pharma-company-profile , Alliance-global-partners , Shaughnessy-asset-management , Ocuphire-pharma-inc , Get-free-report

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Pharma-inc , Evoke-pharma , Free-report , Pharma-stock-down , Get-free-report , Evoke-pharma-daily ,

ABVC BioPharma, Inc. (NASDAQ:ABVC) Sees Significant Decrease in Short Interest

ABVC BioPharma, Inc. (NASDAQ:ABVC – Get Free Report) was the recipient of a significant decrease in short interest during the month of January. As of January 31st, there was short interest totalling 124,000 shares, a decrease of 6.3% from the January 15th total of 132,400 shares. Based on an average daily volume of 2,470,000 shares, […]

United-states , Biopharma-inc , Biopharma-company-profile , Abvc-biopharma-inc , Nasdaq , Exchange-commission , Vanguard-group-inc , Get-free-report , Free-report , Pharma-stock-down , Pharma-company

Acasti Pharma (NASDAQ:ACST) Issues Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Acasti Pharma (NASDAQ:ACST – Get Free Report) released its quarterly earnings results on Monday. The biopharmaceutical company reported ($0.21) EPS for the quarter, beating analysts’ consensus estimates of ($0.23) by $0.02, MarketWatch Earnings reports. Acasti Pharma Stock Down 6.1 % Shares of Acasti Pharma stock opened at $2.45 on Wednesday. Acasti Pharma has a 1 […]

Canada , Acasti-pharma , Craig-hallum , Acasti-pharma-inc , Nasdaq , Renaissance-technologies , Acasti-pharma-company-profile , Get-free-report , Marketwatch-earnings , Pharma-stock-down , Free-report , Pharma-inc